Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
163.36
154.07
168.18
146.55
161.21
147.28
142.49
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
163.36
154.07
168.18
146.55
161.21
147.28
142.49
Raw Material Cost
57.20
60.97
53.93
50.16
57.10
52.75
51.89
Purchase of Finished goods
21.72
15.83
14.75
18.61
21.86
13.33
17.00
(Increase) / Decrease In Stocks
-2.18
-7.42
11.48
-0.13
-6.66
4.16
4.69
Employee Cost
30.36
31.76
27.62
27.98
27.84
29.02
25.05
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
-0.01
0.00
-0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
30.82
29.12
33.69
26.27
32.71
25.29
25.48
Total Expenditure (Excl Depreciation)
137.93
130.26
141.46
122.89
132.84
124.55
124.11
Operating Profit (PBDIT) excl Other Income
25.43
23.81
26.72
23.66
28.37
22.73
18.38
Other Income
7.23
15.27
-6.88
8.97
9.98
10.41
7.02
Operating Profit (PBDIT)
32.66
39.08
19.84
32.63
38.35
33.14
25.40
Interest
0.23
0.21
0.37
0.73
0.35
0.44
0.50
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
32.43
38.87
19.47
31.90
38.00
32.70
24.90
Depreciation
3.62
3.48
3.23
3.22
3.22
3.22
2.69
Profit Before Tax
28.81
35.39
16.25
28.68
34.78
29.48
22.22
Tax
8.83
7.71
4.67
7.91
8.45
5.81
3.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
19.98
27.68
11.58
20.77
26.33
23.67
18.60
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
19.98
27.68
11.58
20.77
26.33
23.67
18.60
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
19.98
27.68
11.58
20.77
26.33
23.67
18.60
Equity Capital
20.03
20.03
20.03
20.03
20.03
20.03
20.03
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
9.98
13.82
5.78
10.37
13.15
11.82
9.29
Diluted Earnings per share
9.98
13.82
5.78
10.37
13.15
11.82
9.28
Operating Profit Margin (Excl OI)
15.57%
15.45%
15.89%
16.14%
17.6%
15.43%
12.9%
Gross Profit Margin
19.85%
25.23%
11.58%
21.77%
23.57%
22.2%
17.47%
PAT Margin
12.23%
17.97%
6.89%
14.17%
16.33%
16.07%
13.05%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 1.33% vs 3.35% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -24.12% vs -4.77% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -10.36% vs -8.92% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -34.29% vs -10.26% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Lincoln Pharma. With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
163.36
192.75
-29.39
-15.25%
Other Operating Income
0.00
0.00
0.00
Total Operating income
163.36
192.75
-29.39
-15.25%
Raw Material Cost
57.20
106.51
-49.31
-46.30%
Purchase of Finished goods
21.72
1.86
19.86
1,067.74%
(Increase) / Decrease In Stocks
-2.18
-1.06
-1.12
-105.66%
Employee Cost
30.36
22.97
7.39
32.17%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
31.51
-31.51
-100.00%
Other Expenses
30.82
0.00
30.82
Total Expenditure (Excl Depreciation)
137.93
161.79
-23.86
-14.75%
Operating Profit (PBDIT) excl Other Income
25.43
30.96
-5.53
-17.86%
Other Income
7.23
1.71
5.52
322.81%
Operating Profit (PBDIT)
32.66
32.67
-0.01
-0.03%
Interest
0.23
0.01
0.22
2,200.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
32.43
32.66
-0.23
-0.70%
Depreciation
3.62
6.17
-2.55
-41.33%
Profit Before Tax
28.81
26.49
2.32
8.76%
Tax
8.83
6.36
2.47
38.84%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
19.98
20.13
-0.15
-0.75%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
19.98
20.13
-0.15
-0.75%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
19.98
20.13
-0.15
-0.75%
Equity Capital
20.03
13.37
6.66
49.81%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
9.98
15.06
-5.08
-33.73%
Diluted Earnings per share
9.98
15.06
-5.08
-33.73%
Operating Profit Margin (Excl OI)
15.57%
16.06%
0.00
-0.49%
Gross Profit Margin
19.85%
16.94%
0.00
2.91%
PAT Margin
12.23%
10.44%
0.00
1.79%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 163.36 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 6.03% vs -8.39% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 1.33% vs 3.35% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 19.98 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is -27.82% vs 139.03% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -24.12% vs -4.77% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 25.43 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 6.80% vs -10.89% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -10.36% vs -8.92% in Sep 2024
Quarterly - Interest
Interest 0.23 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 9.52% vs -43.24% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -34.29% vs -10.26% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.57%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
